Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study suggests that a high frequency of androgenetic alopecia is associated with increased severity of COVID-19 in hospitalized patients.

This study found that autologous platelet-rich plasma significantly improved hair follicle number, thickness, and density in patients with androgenic alopecia compared to placebo, with high reported patient satisfaction.

This study found that non-Caucasian patients are underrepresented in US RCTs for androgenetic alopecia, limiting the generalizability of the findings to the diverse general population.

Corrections were made to a previous work on 3D printing a gel-alginate mix for creating hair follicles, but the main finding - that this method can help grow hair - remains the same.

This study found that Platelet Rich Plasma injection improved hair growth in women with Female Pattern Hair Loss compared to placebo, but larger trials are needed to validate these results.

This research outlines that antiandrogens have mechanisms involving competitive inhibition of androgen binding and enzyme inhibition, with contraindications during pregnancy due to potential fetal risks.

This study found that encapsulating latanoprost in nanotransfersomes increased skin penetration and improved its cell proliferation effect in vitro, suggesting potential for treating hair growth disorders.

This study found that individuals with androgenetic alopecia had higher scalp microbiome diversity and more complex scalp-gut microbiome networks than those without, suggesting a link between skin-gut microorganisms and hair loss development.

This study reported that a new PRP application protocol with two treatments enhanced hair growth metrics in the vertex region of androgenetic alopecia patients within six months.

This study found a significant association between early onset androgenetic alopecia and metabolic syndrome, with higher prevalence of metabolic risk factors in affected individuals compared to a control group.

This study observed that one-third of men with early-onset androgenetic alopecia had altered hormonal profiles, which were associated with increased insulin resistance and more severe hair loss.

In this study, a comprehensive treatment approach involving multiple therapies was found to play a crucial role in managing hidradenitis suppurativa in patients with intellectual and developmental disorders despite practical challenges.

In this study, PRPF treatment was more effective than PRP alone in improving hair count and hair quality in androgenetic alopecia patients, with PRPF showing significant improvements in various hair growth parameters and having no statistical differences observed in the placebo group.

This study concluded that dutasteride 0.5 mg/day improved hair growth in patients with androgenetic alopecia over six months but was associated with a higher prevalence of sexual dysfunction.

This study found that caffeic acid amide derivative, compound 4, effectively inhibited steroid 5α-reductase type 1 in vitro, suggesting potential for development as a treatment for androgenic alopecia.

This study found that a new "bead-jet" printing system for mesenchymal stem cells in Matrigel beads improved skeletal muscle regeneration and skin healing in a high-density, sparse pattern.

In this study, researchers found that using a handheld digital microscope, hair diameter was a better determinant of perceived alopecia severity in androgenetic alopecia than hair density.

In this case study, a combination of PRP, topical minoxidil, and topical finasteride showed significantly better results in treating androgenic alopecia than minoxidil alone for a 35-year-old male patient.

The researchers reported that using exosomes from hair follicle stem cells with acellular nerve allografts helped bridge facial nerve defects in rats and may match the effectiveness of autograft therapy.

This review explores the potential of herbal medicine as an alternative treatment for alopecia areata, suggesting it could improve patient recovery, but reports no new clinical results.

This study found that patients with androgenetic alopecia, especially those who are young, less educated, and single, experience significantly reduced health-related quality of life.

This review discusses various methods to treat androgenetic alopecia in men and reports that certain treatments can significantly alleviate its severity, without presenting new clinical results.

This study found that phytosterols extracted from moringa seed oil may act as potential anti-alopecia agents by inhibiting the 5α-reductase enzyme, with ergostadienol showing particularly high affinity and stability in in silico simulations.

This review discusses various tissue engineering approaches for hair follicle regeneration and biomaterials used, emphasizing its potential despite current clinical challenges.

This study found that individuals with androgenic alopecia in Riyadh, Saudi Arabia, frequently use herbal and home remedies like henna, aloe, yogurt, and eggs, perceiving them as beneficial treatments despite some reporting them as unhelpful.

This study found that topical liquid nitrogen improved pain tolerance during intradermal platelet-rich plasma therapy in androgenic alopecia compared to normal saline, although patient satisfaction did not significantly differ between groups.

In this study, finasteride use in men with androgenetic alopecia was not associated with increased reports of sexual dysfunction compared to non-users, suggesting that finasteride does not cause sexual dysfunction in this context.

This study identified four hub genes that are closely linked to the causative factors of androgenetic alopecia, suggesting potential diagnostic and therapeutic targets.

In this study, a combined treatment for moderate to severe androgenetic alopecia using electric microneedles showed a 100% response rate after 12 weeks, with improvements in hair density and mild side effects, offering promising application prospects.